News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 132
- Sources here
- 19
- Companies here
- 9
Active search
132 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
ASP Isotopes Inc. Announces that Renergen Limited’s Subsidiary has Entered into a Take-or-Pay Contract for the Supply of Liquified Natural Gas to Be Produced at the Virginia Gas Project in South Africa
ASP Isotopes (NASDAQ: ASPI) announced that its subsidiary, Tetra4, has secured a five-year take-or-pay LNG sales contract with a South African food processor for its Virginia Gas Project. This agreement, priced at over $16 per GJ, covers approximately 10% of Phase 1 LNG capacity, …
ASP Isotopes (ASPI) Projected to Announce Quarterly Earnings on Friday
ASP Isotopes (ASPI) is projected to announce its Q2 2026 earnings on Friday, August 14th, with analysts forecasting a loss of $0.17 per share and revenue of $4.47 million. The company reported a smaller loss and higher revenue than expected in the previous quarter. …
Form 8K ASP Isotopes Inc For: 6 August By Investing.com
This article is a brief financial market announcement from Investing.com, stating that ASP Isotopes Inc. filed a Form 8K on August 6. It provides no further details about the filing itself, serving primarily as a news headline. The article also lists various market data …
ASP Isotopes to Participate in Citi’s 2026 Natural Resources Conference
ASP Isotopes Inc. (NASDAQ: ASPI) announced its participation in Citi's 2026 Natural Resources Conference in Las Vegas, Nevada, on Thursday, August 13, 2026, where it will host investor meetings. The company, an advanced materials firm, focuses on developing isotope enrichment technologies for critical materials …
ASP Isotopes to host investor meetings at Citi Natural Resources Conference Aug. 13
ASP Isotopes (ASPI) will host investor meetings at Citi's 2026 Natural Resources Conference in Las Vegas on August 13, 2026. The company's latest investor presentation is available on its website, and a press release mentions proposed merger transactions involving ENDRA, Renergen, and Noble Africa. …
ASP Isotopes projects $14M revenue from PET Labs in 2026
ASP Isotopes Inc. (NASDAQ:ASPI) has outlined significant operational progress across its business units, including projecting $14 million in revenue for its PET Labs division in 2026, up from $6 million in 2025. The company also anticipates commencing helium production at its Renergen subsidiary before …
ASP Isotopes says PET Labs, Renergen, isotope facilities nearing key milestones (ASPI:NASDAQ)
ASP Isotopes (ASPI) has announced significant operational progress across its business units, as detailed in a recent shareholder letter. The company's PET Labs segment reported over 50% organic revenue growth in the first half of 2026, and its isotope facilities and Renergen projects are …
ASP Isotopes Issues Letter to Shareholders
ASP Isotopes Inc. (ASPI) released a letter to shareholders from its Executive Chairman and CEO, Paul Mann, detailing significant progress across its business units, including over 50% organic revenue growth in PET Labs, anticipated helium production at Renergen, and commercial production nearing for Silicon-28 …
Kaspi.kz (NASDAQ:KSPI) rises 3.5% after limited insider sales activity
Kaspi.kz (NASDAQ:KSPI) saw its stock rise by 3.5% last week despite limited insider sales activity from director Vyacheslav Kim, who disposed of 0.15% of his
Joint Stock Company Kaspi.kz (KSPI) 10K Form and Latest SEC Filings 2026
This article provides a comprehensive overview of Joint Stock Company Kaspi.kz's (KSPI) SEC filings, highlighting their importance for investors seeking verified financial data. It details the various types of filings, such as Form 4 for insider ownership changes and Form 20-F for annual financial …
ASP Isotopes to Present at Canaccord Genuity Growth Conference Aug 12
ASP Isotopes (ASPI) will present at Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026. Chief Commercial Officer Viktor Petkov will deliver the company presentation, which will also be available via live audio webcast on the company's investor relations website. The press release …
ASP Isotopes' Aug. 12 presentation will be webcast live
ASP Isotopes (NASDAQ: ASPI) announced that its Chief Commercial Officer, Viktor Petkov, will present at Canaccord Genuity’s 46th Annual Growth Conference on August 12, 2026, at 8:00 a.m. ET. A live webcast and replay of the presentation, focusing on the company's proprietary Aerodynamic Separation …
XY79 Bond Profile — Key Metrics
This article provides a detailed profile of the XY79 bond issued by Kaspi.kz JSC. Key metrics such as coupon rate, maturity date, outstanding amount, and face value are outlined. The article also includes a brief business description of Kaspi.kz JSC, highlighting its Payments, Marketplace, …
ASP Isotopes to Participate in Canaccord Genuity’s 46th Annual Growth Conference on August 12, 2026
ASP Isotopes Inc. announced that its Chief Commercial Officer, Viktor Petkov, will present at Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026. A live webcast and replay will be available on the company's website. The company is focused on developing isotope enrichment …
ASP Isotopes Inc (ASPI) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of ASP Isotopes Inc (ASPI), reporting its current valuation score as 8.28, ranking 98th out of 155 in the Pharmaceuticals industry. The P/E ratio stands at -1.73, which is 34.29% below its recent high and 831.63% above its …
ASPI|ASP Isotopes Inc|Price:3.535|Chg%:-0.240
This article provides a detailed stock analysis of ASP Isotopes Inc (ASPI) by TradingKey, highlighting its healthy fundamentals, high growth potential, and fair valuation. Despite recent weak market performance, the company shows strong underlying financial health and significant institutional ownership. The analysis also includes …
ASBP|Aspire Biopharma Holdings Inc|Price:6.170|Chg%:+0.560
Aspire Biopharma Holdings Inc (ASBP) is an early-stage biopharmaceutical company focused on novel drug delivery mechanisms for FDA-approved drugs, nutraceuticals, and supplements. The company's stock shows strong performance over various periods, including a 1477.10% increase over the last year, despite a high P/E of …
ASP Isotopes Inc (ASPI) Financial Health: Profitability & Balance Sheet Analysis
ASP Isotopes Inc (ASPI) currently holds a financial score of 7.40, ranking 115 out of 155 in the Pharmaceuticals industry, indicating a stable financial status but low operating efficiency. The company reported a significant year-over-year revenue increase of 279.45% to $4.18 million and a …
ASP Isotopes Inc (ASPI) Risk Assessment: Volatility, Financial Risk & Investment Risk
This article provides a risk assessment for ASP Isotopes Inc (ASPI), noting its current score of 2.85, ranking 111 out of 155 in the Pharmaceuticals industry. Key metrics include a beta value of 3.41, indicating high volatility relative to the S&P 500, and a …
ASP Isotopes Announces Capital Markets Day in London on September 8, 2026
ASP Isotopes (NASDAQ: ASPI) has announced it will host a Capital Markets Day in London on September 8, 2026, targeting institutional investors, analysts, and media. The event will provide updates on the company's progress and future plans, including its current portfolio and upcoming projects. …
ASP Isotopes to Detail Nuclear Medicine, Fuels at Sept. 8 Event
ASP Isotopes (NASDAQ: ASPI) announced it will host a Capital Markets Day in London on September 8, 2026, where leadership will provide updates on strategy and commercial momentum, with a detailed focus on nuclear medicine, electronic gases, and nuclear fuels. The event will also …
ASP Isotopes to host London Capital Markets Day Sept 8; webcast, strategy update on nuclear medicine, fuels
ASP Isotopes (ASPI) announced a Capital Markets Day in London on September 8, 2026, where leadership will provide updates on strategy and commercial momentum in nuclear medicine, electronic gases, and nuclear fuels. The event will include a presentation and Q&A, with in-person attendance by …
Aspire Biopharma Holdings Inc (ASBP) Institutional Confidence
This article provides details on the institutional confidence score for Aspire Biopharma Holdings Inc (ASBP), indicating a stable score of 3.00 as of July 28, 2026. It lists key institutional shareholders and their recent activity, showing significant percentage changes in holdings for some, such …
Aspire Biopharma Holdings Inc (ASBP) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of Aspire Biopharma Holdings Inc (ASBP), noting its current valuation score of 6.67 and its rank within the Biotechnology & Medical Research industry. It highlights the company's P/E ratio, mentioning that other relevant financial data such as P/B, …